Financhill
Back

Akzo Nobel NV Vs. Apogee Therapeutics, Inc. Industry Stock Comparison

Sell
37

AKZOF
Akzo Nobel NV

Last Price:
$57.00
Seasonality Move:
2.75%
Sell
44

APGE
Apogee Therapeutics, Inc.

Last Price:
$84.40
Seasonality Move:
-11.77%
Sell
37
Akzo Nobel NV (AKZOF) is a Sell

Is Akzo Nobel NV a Buy, Sell or Hold?

  • The current Akzo Nobel NV [AKZOF] share price is $57.00. The Score for AKZOF is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • AKZOF is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
44
Apogee Therapeutics, Inc. (APGE) is a Sell

Is Apogee Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Apogee Therapeutics, Inc. [APGE] share price is $84.34. The Score for APGE is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • APGE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

AKZOF Stock Price Chart

What is Akzo Nobel NV's stock price today?

  • The Akzo Nobel NV share price today is $57.00
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AKZOF is experiencing slight buying pressure.

APGE Stock Price Chart

What is Apogee Therapeutics, Inc.'s stock price today?

  • The Apogee Therapeutics, Inc. share price today is $84.34
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and APGE is experiencing buying pressure, which is a positive indicator for future bullish movement.

AKZOF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.32 Sell
Relative Strength Index (14 RSI): 5.99 Sell
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (56.42 - 64.94) Sell
Bollinger Bands (100): (61.47 - 70.35) Sell

APGE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.18 Buy
Relative Strength Index (14 RSI): 64.96 Buy
Chaikin Money Flow: 432550 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (69.1 - 79.44) Buy
Bollinger Bands (100): (66.23 - 78.47) Buy

AKZOF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.29 Sell
20-day SMA: 58.83 Sell
50-day SMA: 64.78 Sell
200-day SMA: 68.01 Sell
8-day EMA: 57.46 Sell
20-day EMA: 59.44 Sell
50-day EMA: 62.85 Sell
200-day EMA: 66.21 Sell

APGE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 79.91 Buy
20-day SMA: 75.21 Buy
50-day SMA: 71.36 Buy
200-day SMA: 57.28 Buy
8-day EMA: 80.37 Buy
20-day EMA: 76.41 Buy
50-day EMA: 73.33 Buy
200-day EMA: 61.58 Buy

Akzo Nobel NV Earnings Growth & AKZOF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Apogee Therapeutics, Inc. Earnings Growth & APGE Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.08 per share, a decrease next quarter of $0.21 per share, a decrease this year of $0.63 per share, and a decrease next year of $0.62 per share.

Akzo Nobel NV Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apogee Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):